Pharmaverse
Johnson & Johnson’s Open Source Journey with R in Clinical Trials
Learn how Johnson & Johnson embraces R and open-source tooling in clinical trials.
Abstract: Embracing open source has been a transformative journey for J&J, fueled by a commitment to collaboration, transparency, and innovation. Our R journey began with a mindset shift—transitioning from decades-old solutions to actively contributing to and harnessing the power of open-source communities. We navigated the challenges of cultural adaptation while cultivating a programmer-friendly environment that promotes sharing and continuous learning.
We enhanced our technical capabilities by open-sourcing key projects focused on R and strengthened our ecosystem and industry partnerships. This webinar reflects on our experiences, lessons learned, and the strategic impact of embracing R.
Speakers: Sumesh Kalappurakal, Tadeusz Lewandowski, Nicholas Masel, and Mark Bynens.
Learn more about Posit’s work in Pharma: https://posit.co/use-cases/pharma/